Constipation/fracture
Conditions
Interventions
Healthy people with normal bowel function:None
Placebo-treated group:Placebo
Lactobacillus rhamnosus-treated group:Lactobacillus rhamnosus
Sponsors
People's Hospital of Leshan
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (i) Subjects between 18-70 years of age at the start of the study; (ii) Patients with fractures who have been bedridden for >14 days; (iii) Consent to take the product during the study; (iv) Willingness to sign the consent form
Exclusion criteria
Exclusion criteria: (I) antibiotic or antifungal medication (probiotic three hours later if necessary) during the test; (II) probiotic preparations (tablets, powder, capsules, etc.) 14 days prior to the test; (III) some medication to assist with bowel movements 30 days prior to the test; (IV) abdominal and/or intestinal surgery, except appendectomy, cholecystectomy, non-surgical treatment of haemorrhoids; (V) patients with intestinal obstructive disease; (VI) IBS or functional abdominal pain syndrome as diagnosed by ROMEIV. (VII) The investigator is unsure whether the subject is willing or able to complete the trial; (VIII) The placebo group in the trial; (IX) The subject is participating in another study in the middle of the study; (X) The subject is already constipated at the time of admission.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relieve of constipation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical effect; | — |
Countries
China
Contacts
Public ContactYunlong Zhou
People's Hospital of Leshan
Outcome results
None listed